CMAB vs IMAB in Metastatic Prostate Cancer

NCT00255268 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Prostate Cancer

Interventions

DRUG: Goserelin
DRUG: Bicalutamide

Sponsor

AstraZeneca